Zookeepers spent three years teaching 16-year-old Mahiri how to confidently use an inhaler, which Banham Zoo designed to ...

Daily use of inhaled cannabis linked to increased risks, with risk for asthma significantly increased even with no lifetime tobacco cigarette use ...

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in ...

Research reveals strong connections between muscle strength and cognitive function in patients with COPD, highlighting the potential for rehabilitation strategies.

Queen's University Belfast-led research reports on a multicenter trial finding no significant reduction in pulmonary ...

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...

A new Northwestern Medicine study is challenging long-held assumptions about chronic obstructive pulmonary disease (COPD), ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...

Patients with chronic obstructive pulmonary disease (COPD) face a significant cardiovascular burden both before and after diagnosis. Analyses presented at the European Respiratory Society (ERS) ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies geographically. Large trials are needed to assess safety and effectiveness.

United Therapeutics Corporation ( NASDAQ: UTHR) Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 1:10 PM EDT ...

United Therapeutics UTHR remains poised to expand Tyvaso’s label in the respiratory disease space. It recently unveiled results from the late-stage TETON-2 study, which showed clinical benefit in ...